THE COVID-19 PANDEMIC in 2020 was an unexpected boon for India’s drugs and pharmaceuticals industry: foreign direct investment (FDI) shot up by 188 per cent to $1.5 billion in 202021 from $517 million in 2019-20.
The FDI came into India’s manufacturing prowess in vaccines. The next year, FDI slipped by 5 per cent but surged by 46 per cent in 2022-23.
All this is good news for India’s presidency of the G20 bloc. The G20 presidency, say industry experts, has given centre stage to India, reaffirming its position as a leading player in healthcare and pharmaceuticals.
And it is not just vaccines: over the past five years, top multinationals have been injecting FDI into India’s drugs and pharmaceuticals sector. The Indian pharma sector is the world’s largest provider of generic drugs, with 20 per cent of global exports in terms of volume, according to India Brand Equity Foundation (IBEF), the branding and communications body for trade and exports under the commerce and industry ministry.
Now it’s up to India’s corporates to grab big roles in the world pharma play.
Satish Reddy, Chairman of Dr. Reddy’s Laboratories Ltd, India’s second-largest pharma major by gross sales, says, “India’s G20 presidency plays a crucial role in strengthening the nation’s identity as the world’s pharma hub.”
The G20, a forum of the world’s advanced economies—including the European Union— and developing countries, currently has 23 members, which account for 85 per cent of the world’s GDP. It meets annually to discuss global issues.
Denne historien er fra September 03, 2023-utgaven av Business Today India.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra September 03, 2023-utgaven av Business Today India.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
"Moving to cloud helped us grow❞
What was the problem you were grappling with?
She's Got Time
MORE WOMEN ARE BECOMING WATCH CONNOISSEURS, SEEKING OUT BOTH JEWELLED AND TECHNICAL WATCHES FOR THEIR STYLE AND CRAFTSMANSHIP
RISING STAR
PARUL GULATI IS a name that's been steadily gaining prominence in the Indian entertainment industry after she appeared on season 2 of Shark Tank in 2023. She has become a multifaceted personality who effortlessly transitions between acting and entrepreneurship.
Building on a Legacy
WHEN ZAHABIYA KHORAKIWALA stepped into her role as Managing Director of Wockhardt Hospitals over a decade ago, she confronted formidable challenges that have since turned into achievements.
LEADER IN INNOVATION
AS FEDEX'S PRESIDENT (Middle East, Indian subcontinent and Africa), Kami Viswanathan has a lot on her plate.
WAITING IN THE WINGS
Here are those who missed out as they have not yet completed a year in office; they'll be strong contenders in 2025
A DECENT PROPOSAL
IN TODAY'S WORLD OF TRYING TO CREATE AN EQUITABLE SPACE, BOTH MEN AND WOMEN CONTRIBUTE TO THEIR HOUSEHOLDS. WOMEN ARE ENCOURAGED TO HAVE THEIR OWN SAVINGS POOL AND INVESTMENT ROUTINE. GIVEN THIS, HOW SHOULD FUTURE BRIDES APPROACH FINANCIAL PLANNING?
Women and the STEM Bias
EMPOWERING WOMEN IN STEM WILL NOT ONLY BENEFIT INDIVIDUALS, BUT ALSO STRENGTHEN THE ENTIRE INDUSTRY, DRIVING INNOVATION AND PROGRESS.
ROCKET WOMEN
WOMEN IN INDIA ARE NOT ONLY VENTURING INTO SPACE BUT ARE ALSO STARTING TO SPEARHEAD THE COUNTRY'S EFFORTS IN THE GLOBAL SPACE RACE.
ONE STEP FORWARD
THE NUMBER OF WOMEN INDEPENDENT DIRECTORS IS GROWING STEADILY, BUT IT'S A LONG WAY FROM GENDER PARITY. MUCH MORE NEEDS TO BE DONE TO BREAK THE GLASS CEILING IN BOARDROOMS.
